PARA vs TERN
PARA (PARA) versus Terns Pharmaceuticals Inc (TERN) — a side-by-side from cached financials, not a winner call.
PARA (PARA) common stock.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
PARA does not have a complete income-statement cache yet.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
PARA currently screens at market cap $0. TERN currently screens at market cap $6.12B.
Not investment advice. Open the PARA and TERN stock pages for the full models.
Not investment advice.